Alzheimer’S Disease, Scan, Brain Of A Patient Affected By Alzheimers Disease, Axial Section, Median … More Portion Of Dilated Third Ventricle, Symmetrical Dilation Of Intersections, Whereas The Cortical Horns Are Normal In Size. (Photo By BSIP/Universal Images Group via Getty Images) Universal Images Group via Getty Images Alzheimer’s disease ranks as the sixth leading cause
President Trump on Monday unveiled his plan to dramatically overhaul the way the U.S. pays for drugs by lowering what he calls “inflated” prices to those paid by other countries. Pharma investors didn’t seem to care. The XBI, a closely tracked index of biotech stocks, was up over 4% by midday, while shares of large
Robert F. Kennedy Jr. forcing Peter Marks out of the Food and Drug Administration has blown a hole in the agency’s leadership ranks and threatens to unmoor the oversight of drugs and vaccines from bedrock scientific principles. For biotech investors, Marks’ ouster is a worst-case scenario realized — an FDA riven by dysfunction and uncertainty.